Edition:
United States

Evogene Ltd (EVGN.OQ)

EVGN.OQ on NASDAQ Stock Exchange Global Market

2.87USD
21 May 2018
Change (% chg)

-- (--)
Prev Close
$2.87
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,756
52-wk High
$5.76
52-wk Low
$2.66

Chart for

About

No overview information found for .
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  EVGN.OQ Industry Sector
P/E (TTM): -- 20.77 38.77
EPS (TTM): -- -- --
ROI: -- 4.39 46.42
ROE: -- 5.00 54.22

BRIEF-Evogene And Marrone Bio Innovations Announce Phase Advancement In Their Insect Control Collaboration

* EVOGENE AND MARRONE BIO INNOVATIONS ANNOUNCE PHASE ADVANCEMENT IN THEIR INSECT CONTROL COLLABORATION

May 08 2018

BRIEF-Evogene Reports Q4 Loss Per Share $0.24

* EVOGENE REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Feb 28 2018

BRIEF-Evogene Announces Positive 2nd Year Field Trial Results In Corn Bio-Stimulant Ag-Biologicals Program

* EVOGENE ANNOUNCES POSITIVE 2ND YEAR FIELD TRIAL RESULTS IN CORN BIO-STIMULANT AG-BIOLOGICALS PROGRAM Source text for Eikon: Further company coverage:

Jan 10 2018

BRIEF-Evogene Q3 loss per share $0.20

* Evogene Ltd - ‍in 2018, Evogene expects net cash usage of $14 million to $16 million

Nov 22 2017

Earnings vs. Estimates

No consensus analysis data available.